The current price of ESLA is $0.4101 — it has decreased by 7.53% since the previous close. Data as of Nov 5, 2026.
ESLA is down 43.04% over the past week, down 6.80% over the past month and down 83.98% over the past year. The price is below its 200-day moving average of $0.9806.
Estrella Immunopharma, Inc. has a market capitalization of $17.84M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Estrella Immunopharma, Inc. posted a loss of $0.05 per share, in line with the estimate of -$0.05. Upcoming reports are listed in the earnings calendar.
Estrella Immunopharma, Inc. has not paid any dividends over the past year.
In the latest trading session ESLA moved between $0.40 and $0.4287, a range of 7.00% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Estrella Immunopharma, Inc. shows a strong sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Estrella Immunopharma, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ESLA has traded between $0.24 and $3.01. The current price is 86.38% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.